Integra Lifesciences Prices $450M Senior Secured Notes

By Ahmed Jamerson • Monday, October 12 16:08 • Permanent Link

Integra Lifesciences Holdings said it priced $450 million of 9.500% senior secured notes due 2033 as part of a broader refinancing.

The company said the notes are expected to close on or about Oct. 19, 2026. Proceeds from the offering, together with borrowings under a new credit facility, will be used to refinance existing credit facilities and cover related fees and expenses.

The new debt adds a fixed coupon of 9.500% on the full $450 million principal amount, which implies annual interest expense of about $42.8 million on the notes alone.

The notes are being issued as senior secured obligations and will be guaranteed by Integra’s wholly owned domestic subsidiaries that also guarantee its senior secured credit facilities. Today the company's shares have moved 0.22% to a price of $13.44. If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.